RivoBio is a cutting-edge biopharmaceutical company in Scottsdale, Arizona, dedicated to transforming late-stage cancer treatment through innovative therapeutics and comprehensive biotech services. Our mission centers on developing advanced, targeted therapies while providing strategic research and development support to industry partners. By combining deep scientific expertise with a patient-focused approach, we are committed to pushing the boundaries of therapeutic development research and creating meaningful solutions that address complex medical challenges. Our integrated pipeline and service ecosystem represent a holistic strategy to advance cancer treatment and support biotech innovation.